Chemed (CHE) Stock Price, News & Analysis

Company Overview

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services. Technicians are available around the clock to address emergency repairs, clogged drains, sewer line blockages and water damage mitigation. Roto-Rooter’s service network extends to more than 250 locations nationwide, with a focus on rapid response times and customer satisfaction. The segment also provides preventive maintenance programs designed to help homeowners and businesses protect their plumbing systems.

Vitas Healthcare is one of the nation’s leading providers of end-of-life care, offering hospice and palliative services to terminally ill patients and their families. With a multidisciplinary care model that includes physicians, nurses, social workers, chaplains and trained volunteers, Vitas delivers personalized clinical support, symptom management and emotional counseling. The company also provides bereavement and caregiver support programs, reflecting an emphasis on compassionate, patient-centered care across more than 20 states.

Under the leadership of Chairman and Chief Executive Officer Kenneth C. Brault, Chemed has continued to expand its service capabilities and geographic reach. The company combines strong operational expertise with a commitment to quality, safety and ethical standards. By focusing on critical home services through Roto-Rooter and integrated hospice care via Vitas Healthcare, Chemed aims to address essential needs of American households and vulnerable patient populations.

Key Stats

• Today's Range: $437.42 to $445.46
• 50-Day Range: $368.42 to $441.90
• 52-Week Range: $365.20 to $581.20
• Volume: 162,103 shs
• Average Volume: 265,709 shs
• Market Capitalization: $5.83 billion
• P/E Ratio: 23.96
• Dividend Yield: 0.55%
• Price Target: $501.50
• Consensus Rating: Hold

Chemed Stock Analysis - MarketRank™

Chemed scored higher than 80% of companies evaluated by MarketBeat, and ranked 118th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Chemed has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

Chemed has a consensus price target of $501.50, representing about 14.1% upside from its current price of $439.70.

Amount of Analyst Coverage

Chemed has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 14.26%

Earnings Growth

Earnings for Chemed are expected to grow by 14.26% in the coming year, from $22.30 to $25.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Chemed is 23.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of Chemed is 23.96, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.26.

Price to Earnings Growth Ratio

Chemed has a PEG Ratio of 1.65. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Chemed has a P/B Ratio of 6.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.09% of the float of Chemed has been sold short.

Short Interest Ratio / Days to Cover

Chemed has a short interest ratio ("days to cover") of 1.69, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Chemed has recently increased by 21.99%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Chemed has a dividend yield of 0.55%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Chemed has been increasing its dividend for 16 years.

Dividend Coverage

The dividend payout ratio of Chemed is 13.08%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Chemed will have a dividend payout ratio of 9.42% next year. This indicates that Chemed will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.37

News Sentiment

Chemed has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Chemed this week, compared to 4 articles on an average week.

Search Interest

Only 3 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,648,620.00 in company stock.

Percentage Held by Insiders

3.33% of the stock of Chemed is held by insiders.

Percentage Held by Institutions

95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 3/13 Dividend: 2/23/2026
• Ex-Dividend for 3/13 Dividend: 2/23/2026
• Dividend Payable: 3/13/2026
• Last Earnings: 4/23/2026
• Today: 5/24/2026
• Record date for 6/16 Dividend: 5/28/2026
• Ex-Dividend for 6/16 Dividend: 5/28/2026
• Dividend Payable: 6/16/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Health Care Services
• Current Symbol: NYSE:CHE
• CIK: 19584
• Web: www.chemed.com
• Phone: (513) 762-6690
• Fax: 513-762-6590
• Employees: 15,811
• Year Founded: 1970

Price Target and Rating

• Average Price Target for Chemed: $501.50
• High Price Target: $595.00
• Low Price Target: $436.00
• Potential Upside/Downside: +14.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $18.35
• Trailing P/E Ratio: 23.96
• Forward P/E Ratio: 19.72
• P/E Growth: 1.65
• Net Income: $265.24 million
• Net Margins: 10.23%
• Pretax Margin: 13.73%
• Return on Equity: 27.18%
• Return on Assets: 17.38%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 0.85
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $2.53 billion
• Price / Sales: 2.31
• Cash Flow: $24.69 per share
• Price / Cash Flow: 17.81
• Book Value: $63.88 per share
• Price / Book: 6.88

Miscellaneous

• Outstanding Shares: 13,270,000
• Free Float: 12,832,000
• Market Cap: $5.83 billion
• Optionable: Optionable
• Beta: 0.54